about
Human miR-221/222 in Physiological and Atherosclerotic Vascular RemodelingTargeting vascular (endothelial) dysfunction.The potential of endurance exercise-derived exosomes to treat metabolic diseases.Polychlorinated biphenyl exposure alters the expression profile of microRNAs associated with vascular diseasesMircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesisMicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease.MicroRNA-206 regulates vascular smooth muscle cell phenotypic switch and vascular neointimal formation.
P2860
Q26801898-302C7E2A-DBB6-48BC-9B75-BE32247AB9ADQ38836199-FB8B2687-33F1-4F63-9508-93EF381DA7EBQ38845636-27328510-FC4C-47BD-B86F-23DD473890DEQ41880423-5DEFE3DA-3525-4BFF-B4FE-E2640787B384Q42362245-F2CA6EA8-0E70-4389-B037-9C98EB5E3455Q46822603-F2386955-5E0E-4D94-8403-A1157A0CDC91Q51091066-7EC750A7-0735-4409-974F-698ADF3326EF
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNAs and Cardiovascular Disease.
@en
MicroRNAs and Cardiovascular Disease.
@nl
type
label
MicroRNAs and Cardiovascular Disease.
@en
MicroRNAs and Cardiovascular Disease.
@nl
prefLabel
MicroRNAs and Cardiovascular Disease.
@en
MicroRNAs and Cardiovascular Disease.
@nl
P2860
P1476
MicroRNAs and Cardiovascular Disease.
@en
P2093
Angel Baldán
Carlos Fernández-Hernando
P2860
P2888
P356
10.1007/S40142-013-0008-4
P577
2013-03-01T00:00:00Z